Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (141) 141
life sciences & biomedicine (140) 140
science & technology (140) 140
male (106) 106
middle aged (96) 96
female (92) 92
aged (88) 88
abridged index medicus (76) 76
biological and medical sciences (71) 71
medical sciences (71) 71
cardiovascular system & cardiology (67) 67
risk factors (66) 66
cardiac & cardiovascular systems (53) 53
cardiovascular disease (41) 41
cardiovascular diseases (40) 40
clinical trials (39) 39
double-blind method (39) 39
general & internal medicine (39) 39
medicine, general & internal (38) 38
peripheral vascular disease (36) 36
treatment outcome (36) 36
cardiology. vascular system (31) 31
follow-up studies (30) 30
diabetes (29) 29
pharmacology. drug treatments (29) 29
hypertension (27) 27
hypertension - drug therapy (26) 26
antihypertensive agents - therapeutic use (25) 25
drug therapy (25) 25
heart failure (24) 24
cardiovascular diseases - prevention & control (23) 23
adult (22) 22
prevention (22) 22
angiotensin-converting enzyme inhibitors - therapeutic use (21) 21
blood and lymphatic vessels (20) 20
mortality (20) 20
stroke (20) 20
diabetes mellitus, type 2 - drug therapy (19) 19
medicin och hälsovetenskap (19) 19
analysis (18) 18
atherosclerosis (18) 18
blood pressure (18) 18
cardiovascular system (18) 18
cholesterol (18) 18
drug therapy, combination (18) 18
heart attacks (18) 18
cardiovascular (17) 17
aged, 80 and over (16) 16
proportional hazards models (16) 16
cardiovascular diseases - epidemiology (15) 15
care and treatment (15) 15
diabetes mellitus (15) 15
endocrinology & metabolism (15) 15
general aspects (15) 15
health aspects (15) 15
hypertension - complications (15) 15
patients (15) 15
research (15) 15
risk assessment (15) 15
type 2 diabetes (15) 15
cerebral infarction (14) 14
hypolipidemic agents - therapeutic use (14) 14
myocardial infarction (14) 14
cardiovascular diseases - drug therapy (13) 13
cardiovascular diseases - mortality (13) 13
chlorthalidone - therapeutic use (13) 13
coronary heart disease (13) 13
dosage and administration (13) 13
heart (13) 13
cardiology (12) 12
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (12) 12
hypoglycemic agents - therapeutic use (12) 12
incidence (12) 12
kaplan-meier estimate (12) 12
prospective studies (12) 12
randomized controlled trials as topic (12) 12
time factors (12) 12
glucose (11) 11
miscellaneous (11) 11
united states (11) 11
coronary disease - prevention & control (10) 10
diabetes mellitus, type 2 - complications (10) 10
lipoproteins (10) 10
medicine, research & experimental (10) 10
myocardial infarction - prevention & control (10) 10
regression analysis (10) 10
research & experimental medicine (10) 10
research design (10) 10
african americans (9) 9
amlodipine - therapeutic use (9) 9
antihypertensive agents (9) 9
benzimidazoles - therapeutic use (9) 9
clinical outcomes (9) 9
cohort studies (9) 9
enzymes (9) 9
evaluation (9) 9
heart diseases (9) 9
heart failure - drug therapy (9) 9
lipids (9) 9
lisinopril - therapeutic use (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
by Pfeffer, Marc A and Claggett, Brian and Diaz, Rafael and Dickstein, Kenneth and Gerstein, Hertzel C and Køber, Lars V and Lawson, Francesca C and Ping, Lin and Wei, Xiaodan and Lewis, Eldrin F and Maggioni, Aldo P and McMurray, John J.V and Probstfield, Jeffrey L and Riddle, Matthew C and Solomon, Scott D and Tardif, Jean-Claude and ELIXA Investigators
The New England journal of medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 23, pp. 2247 - 2257
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Glycated Hemoglobin A - analysis | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Proportional Hazards Models | Male | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - complications | Acute Coronary Syndrome - complications | Angina, Unstable - complications | Diabetes Mellitus, Type 2 - mortality | Treatment Failure | Cardiovascular Diseases - epidemiology | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide-1 Receptor - agonists | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Treatment outcome | Care and treatment | Analysis | Hypoglycemic agents | Dosage and administration | Acute coronary syndrome | Myocardial infarction | Cerebral infarction | Glucagon | Diabetes mellitus | Hypersensitivity | Pancreatitis | Angina | Glucose | Hypoglycemia | Morbidity | Studies | Heart rate | Diabetes | Acute coronary syndromes | Cardiovascular diseases | Pancreas | Drug therapy | Diabetes mellitus (non-insulin dependent) | Heart diseases | Glucagon-like peptide 1 | Clinical trials | Regulatory approval | Hemoglobin | Drug dosages | Heart failure | Mortality | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease
by Boden, William E and Miller, Michael G and McBride, Ruth and Harvey, Christopher and Snabes, Michael C and Schmidt, Jeffrey and McGovern, Mark E and Fleg, Jerome L and Desvigne-Nickens, Patrice and Anderson, Todd and Kashyap, Moti and Probstfield, Jeffrey L
The American heart journal, ISSN 0002-8703, 06/2020, Volume 224, pp. 65 - 76
Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiovascular diseases | Testosterone | Risk factors | Myocardial infarction | Plasma | Laboratories | Risk | Cardiovascular disease | Metabolic syndrome | Density | Clinical outcomes | Body mass index | Vitamin B | Atherosclerosis | Hemoglobin | Standard deviation | Lipoproteins (high density) | Heart diseases | Continuity (mathematics) | Hypertension | Cerebral infarction | Stroke | Mortality | Diabetes mellitus | Simvastatin | Health risks | Triglycerides | Angina pectoris | Coronary artery disease | Cholesterol | Studies | Androgens | Hypotheses | Statistical models | Body mass | Arteriosclerosis | Body size | Men | Death | Acute coronary syndromes | Metabolic disorders | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
by The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group and ALLHAT Collaborative Res Grp and ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2981 - 2997
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | Antihypertensive agents | Pharmacology. Drug treatments | Diuretics - economics | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Calcium Channel Blockers - therapeutic use | Lisinopril - economics | Hypertension - drug therapy | Male | Angiotensin-Converting Enzyme Inhibitors - economics | Lisinopril - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Cardiovascular Diseases - epidemiology | Female | Calcium Channel Blockers - economics | Antihypertensive Agents - economics | Chlorthalidone - therapeutic use | Double-Blind Method | Risk Factors | Chlorthalidone - economics | Proportional Hazards Models | Treatment Outcome | Antihypertensive Agents - therapeutic use | Amlodipine - therapeutic use | Diuretics - therapeutic use | Aged | Amlodipine - economics | Hypertension | Diuretics | Evaluation | Cookery for hypertensives | Drug therapy | Thiazides | Prevention | Enzymes | Neurotransmitters | Heart attacks | Clinical trials | Lipids | Health risk assessment | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Spironolactone for Heart Failure with Preserved Ejection Fraction
by Pitt, Bertram and Pfeffer, Marc A and Assmann, Susan F and Boineau, Robin and Anand, Inder S and Claggett, Brian and Clausell, Nadine and Desai, Akshay S and Diaz, Rafael and Fleg, Jerome L and Gordeev, Ivan and Harty, Brian and Heitner, John F and Kenwood, Christopher T and Lewis, Eldrin F and O'Meara, Eileen and Probstfield, Jeffrey L and Shaburishvili, Tamaz and Shah, Sanjiv J and Solomon, Scott D and Sweitzer, Nancy K and Yang, Song and McKinlay, Sonja M and Topcat Investigators and TOPCAT Investigators
The New England journal of medicine, ISSN 0028-4793, 04/2014, Volume 370, Issue 15, pp. 1383 - 1392
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Heart Failure - physiopathology | Kaplan-Meier Estimate | Hospitalization - statistics & numerical data | Mineralocorticoid Receptor Antagonists - adverse effects | Male | Heart Failure - drug therapy | Incidence | Mineralocorticoid Receptor Antagonists - therapeutic use | Stroke Volume | Treatment Failure | Aged, 80 and over | Cardiovascular Diseases - mortality | Female | Aged | Spironolactone - therapeutic use | Spironolactone - adverse effects | Heart Failure - mortality | Heart failure | Prevention | Evaluation | Care and treatment | Usage | Spironolactone | Mortality | United Kingdom | Cardiac output | Creatinine | Hyperkalemia | Heart attacks | Hypokalemia | Ventricle | Drug therapy | Heart diseases | Patients | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
by The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group and ALLHAT Officers Coordinators ALLHA and ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 12/2002, Volume 288, Issue 23, pp. 2998 - 3007
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular system | Biological and medical sciences | Medical sciences | General and cellular metabolism. Vitamins | Antihypertensive agents | Pharmacology. Drug treatments | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Risk Factors | Proportional Hazards Models | Hypertension - drug therapy | Male | Hypercholesterolemia - drug therapy | Cause of Death | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipids - blood | Cardiovascular Diseases - epidemiology | Hypertension - complications | Female | Hypercholesterolemia - complications | Aged | Pravastatin - therapeutic use | Evaluation | Hypercholesterolemia | Pravastatin | Drug therapy | Statins | Anticholesteremic agents | Patients | Clinical outcomes | Cholesterol | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)
by Lippman, Scott M and Klein, Eric A and Goodman, Phyllis J and Lucia, M. Scott and Thompson, Ian M and Ford, Leslie G and Parnes, Howard L and Minasian, Lori M and Gaziano, J. Michael and Hartline, Jo Ann and Parsons, J. Kellogg and Bearden, James D and Crawford, E. David and Goodman, Gary E and Claudio, Jaime and Winquist, Eric and Cook, Elise D and Karp, Daniel D and Walther, Philip and Lieber, Michael M and Kristal, Alan R and Darke, Amy K and Arnold, Kathryn B and Ganz, Patricia A and Santella, Regina M and Albanes, Demetrius and Taylor, Philip R and Probstfield, Jeffrey L and Jagpal, T. J and Crowley, John J and Meyskens, Frank L and Baker, Laurence H and Coltman, Charles A
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 01/2009, Volume 301, Issue 1, pp. 39 - 51
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Tumors of the urinary system | Urinary tract. Prostate gland | Gynecology. Andrology. Obstetrics | General aspects | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Male genital diseases | Tumors | Double-Blind Method | Humans | Middle Aged | Male | Neoplasms - prevention & control | Treatment Outcome | Prostatic Neoplasms - epidemiology | Selenomethionine - therapeutic use | Selenium - therapeutic use | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Vitamin E - therapeutic use | Aged | Prostatic Neoplasms - prevention & control | Dietary Supplements | Neoplasms - epidemiology | Disease prevention | Clinical trials | Selenium | Vitamin E | Prostate cancer | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial
by Riddle, Matthew C and Ambrosius, Walter T and Brillon, David J and Buse, John B and Byington, Robert P and Cohen, Robert M and Goff Jr, David C and Malozowski, Saul and Margolis, Karen L and Probstfield, Jeffrey L and Schnall, Adrian and Seaquist, Elizabeth R and Action Control Cardiovasc Risk Dia and Action to Control Cardiovascular Risk in Diabetes Investigators and for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Investigators
Diabetes care, ISSN 0149-5992, 05/2010, Volume 33, Issue 5, pp. 983 - 990
Life Sciences & Biomedicine | Endocrinology & Metabolism | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Diabetes. Impaired glucose tolerance | Miscellaneous | Biological and medical sciences | Endocrinopathies | Metabolic diseases | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Hypoglycemic Agents - therapeutic use | Multivariate Analysis | Follow-Up Studies | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Risk Factors | Male | Hyperglycemia - drug therapy | Cause of Death | Diabetes Mellitus, Type 2 - mortality | Female | Aged | Hyperglycemia - mortality | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Clinical trials | Pharmaceutical industry | United States | Health aspects | Mortality | Blood pressure | Diabetes | Hypoglycemia | Drug dosages | Pharmaceuticals | Index Medicus | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Strategies for Recruitment and Retention of Participants in Clinical Trials
by Probstfield, Jeffrey L and Frye, Robert L
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 10/2011, Volume 306, Issue 16, pp. 1798 - 1799
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clinical Trials as Topic - economics | United States | Health Personnel | Humans | Professional Role | Organizational Policy | Patient Dropouts | Health Knowledge, Attitudes, Practice | Patient Selection | Medical personnel | Clinical trials | Research ethics | Research grants | Management | Laws, regulations and rules | Participants | Retention | Clinical outcomes | Recruitment | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights